AG003MOP

10238-21-8 | 5-Chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]-amino]sulfonyl]phenyl]-ethyl]-2-methoxybenzamide

AG003MOP

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	10238-21-8
Catalog Number	AG003MOP(AGN-PC-0ORHHH)
Chemical Name	5-Chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]-amino]sulfonyl]phenyl]-ethyl]-2-methoxybenzamide
EC Number	233-570-6
IUPAC Name	5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide
InChI	InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)
InChI Key	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
MDL Number	MFCD00056625
Molecular Formula	C23H28ClN3O5S
Molecular Weight	494.0035
NSC Number	759618
SMILES	ClC=1C=CC(=C(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC2CCCCC2)C1)OC
UNII	SX6K58TVWC
Synonyms	Daonil, Diabeta, Euglucon 5, Euglucon N, Glibenclamide, Glybenclamide, Glyburide, HB 419, HB 420, HB-419, HB-420, HB419, HB420, Maninil, Micronase, Neogluconin, Glibenclamide, glyburide, 10238-21-8, Glybenclamide, Micronase, Diabeta, Glynase, Daonil, Euglucon, Maninil, Semi-daonil, Apo-Glibenclamide, Euglucon 5, Azuglucon, Bastiverit, Benclamin, Betanase, Duraglucon, Euglucan, Euglykon, Glibenil, Glucolon, Neogluconin, Orabetic, Prodiabet, Renabetic, Yuglucon, Dibelet, Gilemal, Glibens, Glibil, Glimel, Glimide, Humedia, Libanil, Suraben, Tiabet, Adiab, Glybenzcyclamide, Melix, Pira, Med-Glionil, Gewaglucon, Glibenbeta, Glibenclamida, Glibenclamidum, Glucohexal, Glucoremed, Hexaglucon, Lisaglucon, Normoglucon, Praeciglucon, Calabren, Cytagon, Euclamin, Glamide, Glibesyn, Glibetic, Gliboral, Glidiabet, Glisulin, Glitisol, Glubate, Glucobene, Glucomid, Glucoven, Glycomin, Lederglib, Miglucan, Debtan, Gliban, Gliben, Glibet, Glicem, Gluben, Glyben, Nadib, Sugril, Novo-Glyburide, Glibenclamid AL, Gen-Glybe, Norglicem 5, Betanese 5, Glibenclamid Fabra, Glibenclamid Basics, Glibenclamid-Cophar, Glibenclamid Heumann, Semi-Euglucon, Glibenclamid Genericon, Hemi-Daonil, Glibenclamid-Ratiopharm, Glibenclamidum [INN-Latin], Glibenclamida [INN-Spanish], Abbenclamide, HB 419, Diabiphage, Glibadone, Semi-Gliben-Puren N, GBN 5, Glibenclamid Riker M., Glyburide (micronized), 5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide, UR 606, Glycron, glyburide (glibenclamide), UNII-SX6K58TVWC, 1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea, C23H28ClN3O5S, HB-419, 1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea, 5-Chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide, U 26452, EINECS 233-570-6, MFCD00056625, SX6K58TVWC, CHEMBL472, BRN 2230085, N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea, MLS000069721, CHEBI:5441, 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide, Urea, 1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexyl-, Benzamide, 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxy-, NCGC00015467-11, SMR000058229, CAS-10238-21-8, 5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide, Euglucon N, Urea, 1-((p-(2-(chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl-, 5-chloro-N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide, 5-chloro-N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-2-methoxybenzamide, DSSTox_CID_17237, DSSTox_RID_79313, N-(4-(beta-(2-Methoxy-5-chlorbenzamido)-aethyl)-benzolsulfonyl)-N'-cyclohexyl-harnstoff, DSSTox_GSID_37237, Benzamide, 5-chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxy-, Micronized glyburide, Glyburide [USAN], W-108874, Glimidstata, Glycolande, PresTab, Gluco-Tablimen, Dia-basan, 1-[[p-[2-(5-Chloro-o-anisamido)ethyl]phenyl]sulfonyl]-3-cyclohexylurea, Gliben-Puren N, 5-chloro-N-(2-{4-[N-(N-cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide, Glyburide (USP), Micronase (TN), 1-{4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonyl}-3-cyclohexylurea;1-{4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonyl}-3-cyclohexylurea, Diabeta (TN), Glynase (TN), GIBENCLAMIDE, Glibenclamid Riker M, SR-01000000196, Glyburide [USAN:USP], HB-420, Amglidia, Delmide, Glyburide(Diabeta), Glibenclamide,(S), GBM, Prestwick_569, Glibenclamide B.P., Glyburide (Diabeta), Glibenclamide [INN], RP-1127, Spectrum_000250, Tocris-0911, Glybenzcyclamide, 99%, Opera_ID_801, Prestwick0_000316, Prestwick1_000316, Prestwick2_000316, Prestwick3_000316, Spectrum2_001816, Spectrum3_001327, Spectrum4_001199, Spectrum5_001631, Lopac-G-0639, ACMC-20a66i, Probes1_000431, Probes2_000378, UPCMLD-DP006, G 0639, AC1L1G1Q, Glibenclamide (JP17/INN), CBiol_001790, Lopac0_000499, Oprea1_764617, SCHEMBL22009, U-26452, BSPBio_000312, BSPBio_001351, BSPBio_003053, KBioGR_000071, KBioGR_001897, KBioSS_000071, KBioSS_000730, MLS001077262, BIDD:GT0239, DivK1c_000481, SPECTRUM2300229, SPBio_001831, SPBio_002531, AC1Q44V7, BPBio1_000344, GTPL2414, DTXSID0037237, UPCMLD-DP006:001, CTK8B7917, HMS501I03, KBio1_000481, KBio2_000071, KBio2_000730, KBio2_002639, KBio2_003298, KBio2_005207, KBio2_005866, KBio3_000141, KBio3_000142, KBio3_002273, AOB6214, SYN3026, Glybenclamide, >=99% (HPLC), NINDS_000481, ZNNLBTZKUZBEKO-UHFFFAOYSA-N, Bio1_000076, Bio1_000565, Bio1_001054, Bio2_000071, Bio2_000551, HMS1361D13, HMS1568P14, HMS1791D13, HMS1922L08, HMS1989D13, HMS2089L06, HMS2093P04, HMS2095P14, HMS3259O12, HMS3261D19, HMS3267A15, HMS3402D13, HMS3428D15, HMS3651E17, HMS3675F16, HMS3712P14, Pharmakon1600-02300229, ZINC537805, BCP05327, Tox21_110158, Tox21_300758, Tox21_500499, ANW-58936, BDBM50012957, BG0207, CCG-39618, GP8701, HD 419, NSC759618, SBB057426, STK362992, AKOS001487495, N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea, Tox21_110158_1, BCP9000729, CS-1075, DB01016, KS-5326, LP00499, MCULE-2351642942, NC00566, NSC-759618, SB17414, IDI1_000481, IDI1_033821, Glibenclamide 1.0 mg/ml in Acetonitrile, NCGC00015467-01, NCGC00015467-02, NCGC00015467-03, NCGC00015467-04, NCGC00015467-05, NCGC00015467-06, NCGC00015467-07, NCGC00015467-08, NCGC00015467-09, NCGC00015467-10, NCGC00015467-12, NCGC00015467-13, NCGC00015467-14, NCGC00015467-15, NCGC00015467-16, NCGC00015467-17, NCGC00015467-18, NCGC00015467-20, NCGC00015467-36, NCGC00016689-01, NCGC00023447-02, NCGC00023447-04, NCGC00023447-05, NCGC00023447-06, NCGC00023447-07, NCGC00023447-08, NCGC00023447-09, NCGC00023447-10, NCGC00023447-11, NCGC00023447-12, NCGC00254662-01, NCGC00261184-01, 5-Chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]-amino]sulfonyl]phenyl]-ethyl]-2-methoxybenzamide, AJ-23371, AN-20367, CPD000058229, HY-15206, SAM002564212, SC-17437, ST024780, SBI-0050483.P003, AB0012611, AB2000243, Glyburide, meets USP testing specifications, LS-159295, RT-000122, AB00051949, EU-0100499, FT-0601608, G-150, G0382, S1716, SW195828-5, A19539, C07022, D00336, J10021, W-5054, 78637-EP2270001A1, 78637-EP2270011A1, 78637-EP2272825A2, 78637-EP2272841A1, 78637-EP2275414A1, 78637-EP2287165A2, 78637-EP2287166A2, 78637-EP2292620A2, 78637-EP2298750A1, 78637-EP2298776A1, 78637-EP2298779A1, 78637-EP2301923A1, 78637-EP2301936A1, 78637-EP2305648A1, 78637-EP2308847A1, AB00051949-16, AB00051949-17, AB00051949_18, AB00051949_19, C-22898, I06-0716, SR-01000000196-2, SR-01000000196-4, SR-01000000196-5, SR-01000000196-6, SR-01000000196-8, U-26,452, BRD-K36927236-001-06-0, BRD-K36927236-001-17-7, Z277540138, Glybenclamide, European Pharmacopoeia (EP) Reference Standard, Glyburide, United States Pharmacopeia (USP) Reference Standard, 1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl urea, 5-Chloro-N-[4-(3-cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide, 5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)-phenethyl)-2-methoxybenzamide, 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide, 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide., 5-chloro-N-[4-({[(cyclohexylamino)carbonyl]amino}sulfonyl)phenethyl]-2-methoxybenzamide, Glibenclamide for peak identification, European Pharmacopoeia (EP) Reference Standard, Glyburide (Glibenclamide), Pharmaceutical Secondary Standard; Certified Reference Material, N-(4-(.beta.-(2-Methoxy-5-chlorbenzamido)-aethyl)-benzolsulfonyl)-N'-cyclohexyl-harnstoff, N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N -cyclohexylurea, N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N'-cyclohexylurea, (5-chloro-2-methoxyphenyl)-N-[2-(4-{[(cyclohexylamino)carbonylamino]sulfonyl}p henyl)ethyl]carboxamide, 5-Chloro-N-(2-[4-(([(cyclohexylamino)carbonyl]amino)sulfonyl)phenyl]ethyl)-2-methoxybenzamide #, 5-Chloro-N-[2-[4-[[[(Cylcohexylamino)carbonyl]amino]sulphonyl]phenyl]ethyl]-2-methoxybenzamide, N-[(4-{2-[(5-chloro-2-methoxyphenyl)carbonylamino]ethyl}phenyl)sulfonyl](cyclo hexylamino)carboxamide, glicuformine, Glucovance, Malix, Euglucon (TN), Daonil (TN), Semi-Daonil (TN), D05LYX, Glibenclamide (JP15/INN), HB419, HB420, CID3488, HB 420, C23-H28-Cl-N3-O5-S, Glyburide, 98% - 100G 100g, ACN-048745, CS-O-01584, B1296, B1948, A10433, D005905, Benzamide, 5-chloro-N-[2-[4-[[[(cyclohexylamino) carbonyl]amino]sulfonyl]phenyl]ethyl] -2-methoxy-, Urea, 1-[[p-[2-(5-chloro-o-anisamido)ethyl]phenyl]sulfonyl]-3-cyclohexyl-, Glibenclamide;Glycron;Glynase;Micronase;Daonil;Semi-Daonil;Euglucon;Delmide;Diabeta, N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N-cyclohexylurea, 5-Chloro-N-[2-[4-[[[(cy-clohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxybenzamide, Benzamida, 5-cloro-N-[2-[4-[[[( ciclohexilamino) carbonil] amino] sulfonil] fenil] etil]-2-metoxi-,

Complexity	746
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	493.144g/mol
Formal Charge	0
Heavy Atom Count	33
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	3
Isotope Atom Count	0
Molecular Weight	494.003g/mol
Monoisotopic Mass	493.144g/mol
Rotatable Bond Count	8
Topological Polar Surface Area	122A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	4.8

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H413
Packing Group
Precautionary statements	P264-P270-P273-P301+P312-P330
UN Code

Certificate of Analysis

Lot Number